Clinical Trial Update: S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial S0430 evaluated cyclophosphamide plus capecitabine in women with stage IV/metastatic breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-06-27